S&P 500   2,995.03 (-0.03%)
DOW   26,754.85 (-0.12%)
QQQ   191.56 (-0.15%)
AAPL   242.28 (+0.97%)
FB   184.88 (+1.39%)
MSFT   136.17 (-0.15%)
GOOGL   1,252.74 (+0.93%)
AMZN   1,756.90 (-0.50%)
CGC   21.69 (+2.55%)
NVDA   192.94 (-1.36%)
MU   44.51 (-0.34%)
BABA   168.68 (-0.71%)
GE   9.07 (+0.00%)
AMD   31.21 (-0.95%)
T   37.69 (-1.26%)
F   9.10 (+0.33%)
ACB   3.67 (+2.51%)
NFLX   270.34 (+1.37%)
GILD   66.47 (+0.93%)
DIS   131.21 (-0.90%)
S&P 500   2,995.03 (-0.03%)
DOW   26,754.85 (-0.12%)
QQQ   191.56 (-0.15%)
AAPL   242.28 (+0.97%)
FB   184.88 (+1.39%)
MSFT   136.17 (-0.15%)
GOOGL   1,252.74 (+0.93%)
AMZN   1,756.90 (-0.50%)
CGC   21.69 (+2.55%)
NVDA   192.94 (-1.36%)
MU   44.51 (-0.34%)
BABA   168.68 (-0.71%)
GE   9.07 (+0.00%)
AMD   31.21 (-0.95%)
T   37.69 (-1.26%)
F   9.10 (+0.33%)
ACB   3.67 (+2.51%)
NFLX   270.34 (+1.37%)
GILD   66.47 (+0.93%)
DIS   131.21 (-0.90%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Marinus PharmaceuticalsMillendo TherapeuticsAgeX TherapeuticsIterum TherapeuticsHumanigen
SymbolNASDAQ:MRNSNASDAQ:MLNDNYSE:AGENASDAQ:ITRMOTCMKTS:HGEN
Price Information
Current Price$1.27$7.21$1.68$3.52$0.88
52 Week RangeBuyBuyN/ABuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyN/A
Consensus Price Target$9.67$25.14N/A$18.00N/A
% Upside from Price Target661.53% upside248.72% upsideN/A411.36% upsideN/A
Trade Information
Market Cap$67.30 million$93.62 million$63.97 million$51.09 million$78.95 million
Beta2.892.74N/A2.013.07
Average Volume2,210,02931,11888,67620,2643,433
Sales & Book Value
Annual RevenueN/A$290,000.00$1.40 million$870,000.00N/A
Price / SalesN/A333.4045.1656.48N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.30 per share$5.66 per share$0.23 per share$5.13 per share($0.07) per share
Price / BookN/A1.277.300.69N/A
Profitability
Net Income$-36,730,000.00$-27,190,000.00$-7,500,000.00$-77,060,000.00$-12,000,000.00
EPS($0.90)($17.58)N/A($7.11)N/A
Trailing P/E RatioN/AN/A0.00N/A0.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-11,956.64%N/A
Return on Equity (ROE)-88.80%-64.18%N/A-136.21%N/A
Return on Assets (ROA)-75.65%-55.07%N/A-87.84%-643.35%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.04%0.03%0.44%N/A
Current Ratio5.89%5.90%2.54%2.10%0.16%
Quick Ratio5.89%5.90%2.54%2.10%0.16%
Ownership Information
Institutional Ownership Percentage64.13%50.47%16.88%43.63%N/A
Insider Ownership Percentage5.10%3.70%N/A51.10%7.10%
Miscellaneous
Employees2832N/A483
Shares Outstanding52.58 million13.41 million37.63 million13.96 million112.79 million
Next Earnings Date11/4/2019 (Estimated)11/11/2019 (Estimated)11/13/2019 (Estimated)11/13/2019 (Estimated)11/11/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
 Marinus PharmaceuticalsMillendo TherapeuticsAgeX TherapeuticsIterum TherapeuticsHumanigen

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel